Abbott Laboratories receives FDA clearance for OTC sales of Lingo and Libre Rio continuous glucose monitoring systems.
Abbott Laboratories receives FDA clearance for OTC sales of continuous glucose monitoring systems Lingo and Libre Rio. Lingo targets general health and wellness, while Libre Rio focuses on Type 2 diabetes adults who manage their condition via lifestyle changes. These OTC devices follow FDA's approval of Dexcom's Stelo in March, marking the first continuous glucose monitor available without a prescription.
June 10, 2024
8 Articles